0 XP   0   0   0

Adc Therapeutics SA
Buy, Hold or Sell?

Should you buy, hold or sell Adc Therapeutics SA?

I guess you are interested in Adc Therapeutics SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Adc Therapeutics SA

Let's start. I'm going to help you getting a better view of Adc Therapeutics SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Adc Therapeutics SA even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Adc Therapeutics SA is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Adc Therapeutics SA. The closing price on 2023-01-27 was $5.05 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Adc Therapeutics SA Daily Candlestick Chart
Adc Therapeutics SA Daily Candlestick Chart
Summary









1. Valuation of Adc Therapeutics SA




Current price per share

$5.05

2. Growth of Adc Therapeutics SA




Is Adc Therapeutics SA growing?

Current yearPrevious yearGrowGrow %
How rich?$104.7m$266.1m-$128.9m-94.0%

How much money is Adc Therapeutics SA making?

Current yearPrevious yearGrowGrow %
Making money-$41.5m-$62.8m$21.3m51.5%
Net Profit Margin-169.1%-618.6%--

How much money comes from the company's main activities?

3. Financial Health of Adc Therapeutics SA




Comparing to competitors in the Biotechnology industry




  Industry Rankings (Biotechnology)  


Richest
#542 / 1232

Most Revenue
#226 / 1232

Most Profit
#1009 / 1232

Most Efficient
#753 / 1232


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Adc Therapeutics SA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Adc Therapeutics SA earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Adc Therapeutics SA to the Biotechnology industry mean.
  • A Net Profit Margin of -66.3% means that $-0.66 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Adc Therapeutics SA:

  • The MRQ is -66.3%. The company is making a huge loss. -2
  • The TTM is -169.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-66.3%TTM-169.1%+102.8%
TTM-169.1%YOY-618.6%+449.4%
TTM-169.1%5Y-1,081.5%+912.4%
5Y-1,081.5%10Y-1,081.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-66.3%-223.6%+157.3%
TTM-169.1%-281.7%+112.6%
YOY-618.6%-344.8%-273.8%
5Y-1,081.5%-450.1%-631.4%
10Y-1,081.5%-541.0%-540.5%
1.1.2. Return on Assets

Shows how efficient Adc Therapeutics SA is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Adc Therapeutics SA to the Biotechnology industry mean.
  • -9.5% Return on Assets means that Adc Therapeutics SA generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Adc Therapeutics SA:

  • The MRQ is -9.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.5%TTM-7.6%-1.9%
TTM-7.6%YOY-12.2%+4.6%
TTM-7.6%5Y-14.3%+6.7%
5Y-14.3%10Y-14.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.5%-9.9%+0.4%
TTM-7.6%-8.9%+1.3%
YOY-12.2%-9.3%-2.9%
5Y-14.3%-11.7%-2.6%
10Y-14.3%-12.7%-1.6%
1.1.3. Return on Equity

Shows how efficient Adc Therapeutics SA is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Adc Therapeutics SA to the Biotechnology industry mean.
  • -48.3% Return on Equity means Adc Therapeutics SA generated $-0.48 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Adc Therapeutics SA:

  • The MRQ is -48.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -33.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-48.3%TTM-33.8%-14.5%
TTM-33.8%YOY-25.5%-8.3%
TTM-33.8%5Y-28.1%-5.7%
5Y-28.1%10Y-28.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-48.3%-12.0%-36.3%
TTM-33.8%-11.5%-22.3%
YOY-25.5%-10.8%-14.7%
5Y-28.1%-14.2%-13.9%
10Y-28.1%-15.2%-12.9%

1.2. Operating Efficiency of Adc Therapeutics SA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Adc Therapeutics SA is operating .

  • Measures how much profit Adc Therapeutics SA makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Adc Therapeutics SA to the Biotechnology industry mean.
  • An Operating Margin of -52.4% means the company generated $-0.52  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Adc Therapeutics SA:

  • The MRQ is -52.4%. The company is operating very inefficient. -2
  • The TTM is -227.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-52.4%TTM-227.4%+175.1%
TTM-227.4%YOY-591.6%+364.2%
TTM-227.4%5Y-1,108.7%+881.3%
5Y-1,108.7%10Y-1,108.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-52.4%-207.3%+154.9%
TTM-227.4%-271.0%+43.6%
YOY-591.6%-325.9%-265.7%
5Y-1,108.7%-454.0%-654.7%
10Y-1,108.7%-537.1%-571.6%
1.2.2. Operating Ratio

Measures how efficient Adc Therapeutics SA is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.04 means that the operating costs are $1.04 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Adc Therapeutics SA:

  • The MRQ is 1.041. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.200. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.041TTM3.200-2.160
TTM3.200YOY6.285-3.085
TTM3.2005Y18.726-15.525
5Y18.72610Y18.7260.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0412.871-1.830
TTM3.2003.504-0.304
YOY6.2853.604+2.681
5Y18.7265.132+13.594
10Y18.7266.371+12.355

1.3. Liquidity of Adc Therapeutics SA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Adc Therapeutics SA is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.00 means the company has $5.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Adc Therapeutics SA:

  • The MRQ is 5.003. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.189. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.003TTM6.189-1.187
TTM6.189YOY9.471-3.281
TTM6.1895Y7.734-1.545
5Y7.73410Y7.7340.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.0035.117-0.114
TTM6.1895.755+0.434
YOY9.4715.854+3.617
5Y7.7346.511+1.223
10Y7.7346.222+1.512
1.3.2. Quick Ratio

Measures if Adc Therapeutics SA is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Adc Therapeutics SA to the Biotechnology industry mean.
  • A Quick Ratio of 4.61 means the company can pay off $4.61 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Adc Therapeutics SA:

  • The MRQ is 4.615. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.424. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ4.615TTM1.424+3.191
TTM1.424YOY4.128-2.704
TTM1.4245Y3.705-2.281
5Y3.70510Y3.7050.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6154.284+0.331
TTM1.4244.664-3.240
YOY4.1284.787-0.659
5Y3.7055.218-1.513
10Y3.7055.182-1.477

1.4. Solvency of Adc Therapeutics SA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Adc Therapeutics SA assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Adc Therapeutics SA to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.80 means that Adc Therapeutics SA assets are financed with 80.3% credit (debt) and the remaining percentage (100% - 80.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Adc Therapeutics SA:

  • The MRQ is 0.803. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.758. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.803TTM0.758+0.045
TTM0.758YOY0.471+0.288
TTM0.7585Y0.444+0.314
5Y0.44410Y0.4440.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8030.278+0.525
TTM0.7580.277+0.481
YOY0.4710.306+0.165
5Y0.4440.367+0.077
10Y0.4440.403+0.041
1.4.2. Debt to Equity Ratio

Measures if Adc Therapeutics SA is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Adc Therapeutics SA to the Biotechnology industry mean.
  • A Debt to Equity ratio of 407.5% means that company has $4.07 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Adc Therapeutics SA:

  • The MRQ is 4.075. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.221. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.075TTM3.221+0.854
TTM3.221YOY1.098+2.124
TTM3.2215Y1.475+1.746
5Y1.47510Y1.4750.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0750.315+3.760
TTM3.2210.317+2.904
YOY1.0980.319+0.779
5Y1.4750.403+1.072
10Y1.4750.462+1.013

2. Market Valuation of Adc Therapeutics SA

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Adc Therapeutics SA generates.

  • Above 15 is considered overpriced but always compare Adc Therapeutics SA to the Biotechnology industry mean.
  • A PE ratio of -7.46 means the investor is paying $-7.46 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Adc Therapeutics SA:

  • The EOD is -7.821. Company is losing money. -2
  • The MRQ is -7.464. Company is losing money. -2
  • The TTM is -32.783. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-7.821MRQ-7.464-0.356
MRQ-7.464TTM-32.783+25.319
TTM-32.783YOY-34.187+1.404
TTM-32.7835Y-26.413-6.370
5Y-26.41310Y-26.4130.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.821-8.986+1.165
MRQ-7.464-9.792+2.328
TTM-32.783-16.243-16.540
YOY-34.187-20.876-13.311
5Y-26.413-16.665-9.748
10Y-26.413-14.732-11.681
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Adc Therapeutics SA.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Adc Therapeutics SA:

  • The MRQ is -6.113. Very Bad. -2
  • The TTM is -19.042. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-6.113TTM-19.042+12.929
TTM-19.042YOY-12.014-7.028
TTM-19.0425Y-24.889+5.847
5Y-24.88910Y-24.8890.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.113-0.032-6.081
TTM-19.0420.004-19.046
YOY-12.0140.016-12.030
5Y-24.8890.006-24.895
10Y-24.8890.003-24.892

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Adc Therapeutics SA is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.61 means the investor is paying $3.61 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Adc Therapeutics SA:

  • The EOD is 3.777. Neutral. Compare to industry.
  • The MRQ is 3.605. Neutral. Compare to industry.
  • The TTM is 6.353. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD3.777MRQ3.605+0.172
MRQ3.605TTM6.353-2.748
TTM6.353YOY8.195-1.842
TTM6.3535Y5.220+1.133
5Y5.22010Y5.2200.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.7771.835+1.942
MRQ3.6052.006+1.599
TTM6.3532.774+3.579
YOY8.1953.453+4.742
5Y5.2202.713+2.507
10Y5.2202.402+2.818
2. Total Gains per Share

2.4. Latest News of Adc Therapeutics SA

Does Adc Therapeutics SA still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Adc Therapeutics SA to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2023-01-16
15:55
Wall Street Analysts Think ADC Therapeutics SA (ADCT) Could Surge 174.2%: Read This Before Placing a BetRead
2023-01-13
13:28
ADC Therapeutics SA (ADCT) Stock Jumps 21.8%: Will It Continue to Soar?Read

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Adc Therapeutics SA.

3.1. Institutions holding Adc Therapeutics SA

Institutions are holding 51.522% of the shares of Adc Therapeutics SA.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-09-30FMR Inc9.88230.00397673137-7909-0.103
2022-09-30Redmile Group, LLC9.67481.4044751202900
2022-09-30JPMorgan Chase & Co4.40020.00243416517-37155-1.0758
2022-09-30AllianceBernstein L.P.3.75450.00682915160-46464-1.5689
2022-09-30Deerfield Management Co3.07850.2293239029723902970
2022-09-30Eventide Asset Management, LLC2.42120.1783187995900
2022-09-30T. Rowe Price Associates, Inc.1.53360.00091190754-770456-39.2847
2022-09-30Vantage Consulting Group Inc.1.52773.3406118621500
2022-09-30GCM Grosvenor Holdings, LLC0.94720.84735471-562541-43.3387
2022-09-30Blue Owl Capital Holdings LP0.94481.53147335687335680
2022-09-30Walleye Trading Advisors, LLC0.89670.0641696263-192437-21.6538
2022-09-30Hillhouse Capital Advisors, Ltd.0.6440.063450000000
2022-09-30American Century Companies Inc0.58170.0019451637-190-0.0421
2022-09-30BlackRock Inc0.55110.0001427866-38938-8.3414
2022-09-30Millennium Management LLC0.54120.0012420253362288625.0116
2022-09-30Principal Financial Group Inc0.51570.0015400400-5702-1.4041
2022-09-30Matrix Capital Management Company, LLC0.51520.036940000000
2022-09-30ExodusPoint Capital Management, LP0.47570.0233369386230194165.3788
2022-09-30MPM Oncology Impact Management LP0.43070.381833438400
2022-09-30Morgan Stanley - Brokerage Accounts0.36450.00022830127744437.6732
Total 43.68138.112433916308+2131999+6.3%

3.2. Funds holding Adc Therapeutics SA

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-10-31Fidelity® Select Health Care1.39090.0573108000000
2022-10-31AB Small Cap Growth A1.30930.11241016606-10550-1.0271
2022-11-30JPM Global Healthcare C (acc) USD1.20210.065493334800
2022-10-31Fidelity® Select Biotechnology0.97270.06475523800
2022-10-31Fidelity® Growth Company0.95480.0079741336-20620-2.7062
2022-05-31Pictet-Biotech P USD0.94060.3539730326-19515-2.6026
2022-10-31Fidelity Growth Compy Commingled Pl 30.91770.0064712562-261934-26.8789
2022-10-31Fidelity Advisor® Health Care I0.90150.053370000000
2022-10-31AB Discovery Growth A0.86540.1116671946-9500-1.3941
2022-10-31Fidelity Advisor® Biotechnology I0.61050.118147402300
2022-05-31Pictet-Global Megatrend Sel I USD0.55850.0244433627-12149-2.7254
2022-10-31Fidelity® Select Pharmaceuticals Port0.54050.234241970000
2022-09-30American Century U.S. Small Cap Gr SMA0.52490.105240755000
2022-09-30American Century Small Cap Growth Inv0.52490.104240755000
2022-08-31MEDICAL BioHealth EUR Acc0.5110.384839675400
2022-09-30Fidelity® Series Small Cap Opps0.43970.038134141000
2022-11-30iShares Biotechnology ETF0.39740.0127308591-472-0.1527
2022-10-31Principal SmallCap R50.35420.101127500000
2022-10-31Fidelity® Series Large Cap Stock0.31320.007724320900
2022-10-31Fidelity Advisor® Growth Opps M0.30670.007223817400
Total 14.53651.969911286950-334740-3.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Adc Therapeutics SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.149-0.269+81%-0.608+309%-0.266+79%-0.266+79%
Book Value Growth--0.9080.871+4%0.842+8%0.973-7%0.973-7%
Book Value Per Share--1.3371.764-24%3.428-61%2.717-51%2.717-51%
Book Value Per Share Growth--0.9000.869+4%0.842+7%0.972-7%0.972-7%
Current Ratio--5.0036.189-19%9.471-47%7.734-35%7.734-35%
Debt To Asset Ratio--0.8030.758+6%0.471+71%0.444+81%0.444+81%
Debt To Equity Ratio--4.0753.221+26%1.098+271%1.475+176%1.475+176%
Dividend Per Share----0%-0%-0%-0%
Eps---0.646-0.533-17%-0.810+25%-0.639-1%-0.639-1%
Eps Growth--1.2210.598+104%0.483+153%0.668+83%0.668+83%
Free Cash Flow Per Share--0.025-0.480+2038%-0.741+3091%-0.548+2313%-0.548+2313%
Free Cash Flow Per Share Growth--2.0361.229+66%0.924+120%0.901+126%0.901+126%
Free Cash Flow To Equity Per Share--0.055-0.478+970%0.115-52%0.312-82%0.312-82%
Free Cash Flow To Equity Per Share Growth--2.0790.897+132%4.620-55%2.184-5%2.184-5%
Gross Profit Margin--1.0001.0000%1.052-5%1.013-1%1.013-1%
Intrinsic Value_10Y_max---38.464--------
Intrinsic Value_10Y_min---78.537--------
Intrinsic Value_1Y_max---2.203--------
Intrinsic Value_1Y_min---3.254--------
Intrinsic Value_3Y_max---7.877--------
Intrinsic Value_3Y_min---13.832--------
Intrinsic Value_5Y_max---15.069--------
Intrinsic Value_5Y_min---28.775--------
Net Profit Margin---0.663-1.691+155%-6.186+833%-10.815+1531%-10.815+1531%
Operating Margin---0.524-2.274+334%-5.916+1030%-11.087+2017%-11.087+2017%
Operating Ratio--1.0413.200-67%6.285-83%18.726-94%18.726-94%
Pb Ratio3.777+5%3.6056.353-43%8.195-56%5.220-31%5.220-31%
Pe Ratio-7.821-5%-7.464-32.783+339%-34.187+358%-26.413+254%-26.413+254%
Peg Ratio---6.113-19.042+212%-12.014+97%-24.889+307%-24.889+307%
Price Per Share5.050+5%4.82011.915-60%26.983-82%14.712-67%14.712-67%
Price To Total Gains Ratio-33.991-5%-32.443-113.204+249%-46.003+42%-57.989+79%-57.989+79%
Profit Growth--1.2140.596+104%0.483+151%0.409+197%0.409+197%
Quick Ratio--4.6151.424+224%4.128+12%3.705+25%3.705+25%
Return On Assets---0.095-0.076-20%-0.122+28%-0.143+50%-0.143+50%
Return On Equity---0.483-0.338-30%-0.255-47%-0.281-42%-0.281-42%
Revenue Growth--4.4142.203+100%3.497+26%2.006+120%2.006+120%
Total Gains Per Share---0.149-0.269+81%-0.608+309%-0.266+79%-0.266+79%
Total Gains Per Share Growth--1.756-1.653+194%0.590+197%0.155+1033%0.155+1033%
Usd Book Value--104783000.000137221000.000-24%266174750.000-61%211038937.500-50%211038937.500-50%
Usd Book Value Change Per Share---0.149-0.269+81%-0.608+309%-0.266+79%-0.266+79%
Usd Book Value Per Share--1.3371.764-24%3.428-61%2.717-51%2.717-51%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.646-0.533-17%-0.810+25%-0.639-1%-0.639-1%
Usd Free Cash Flow--1941000.000-37260500.000+2020%-57514500.000+3063%-36753125.000+1994%-36753125.000+1994%
Usd Free Cash Flow Per Share--0.025-0.480+2038%-0.741+3091%-0.548+2313%-0.548+2313%
Usd Free Cash Flow To Equity Per Share--0.055-0.478+970%0.115-52%0.312-82%0.312-82%
Usd Price Per Share5.050+5%4.82011.915-60%26.983-82%14.712-67%14.712-67%
Usd Profit---50608000.000-41506000.000-18%-62893500.000+24%-48767875.000-4%-48767875.000-4%
Usd Revenue--76321000.00039280000.000+94%4226750.000+1706%11115593.750+587%11115593.750+587%
Usd Total Gains Per Share---0.149-0.269+81%-0.608+309%-0.266+79%-0.266+79%
 EOD+2 -3MRQTTM+25 -14YOY+26 -145Y+21 -1910Y+21 -19

4.2. Fundamental Score

Let's check the fundamental score of Adc Therapeutics SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.821
Price to Book Ratio (EOD)Between0-13.777
Net Profit Margin (MRQ)Greater than0-0.663
Operating Margin (MRQ)Greater than0-0.524
Quick Ratio (MRQ)Greater than14.615
Current Ratio (MRQ)Greater than15.003
Debt to Asset Ratio (MRQ)Less than10.803
Debt to Equity Ratio (MRQ)Less than14.075
Return on Equity (MRQ)Greater than0.15-0.483
Return on Assets (MRQ)Greater than0.05-0.095
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Adc Therapeutics SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.341
Ma 20Greater thanMa 504.367
Ma 50Greater thanMa 1003.828
Ma 100Greater thanMa 2004.346
OpenGreater thanClose4.700
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets531,759
Total Liabilities426,976
Total Stockholder Equity104,783
 As reported
Total Liabilities 426,976
Total Stockholder Equity+ 104,783
Total Assets = 531,759

Assets

Total Assets531,759
Total Current Assets438,099
Long-term Assets438,099
Total Current Assets
Cash And Cash Equivalents 380,860
Net Receivables 23,251
Inventory 15,745
Other Current Assets 18,243
Total Current Assets  (as reported)438,099
Total Current Assets  (calculated)438,099
+/-0
Long-term Assets
Property Plant Equipment 9,877
Long Term Investments 34,687
Intangible Assets 14,598
Other Assets 35,452
Long-term Assets  (as reported)93,660
Long-term Assets  (calculated)94,614
+/- 954

Liabilities & Shareholders' Equity

Total Current Liabilities87,573
Long-term Liabilities339,403
Total Stockholder Equity104,783
Total Current Liabilities
Short-term Debt 13,304
Short Long Term Debt 12,469
Accounts payable 11,611
Other Current Liabilities 62,658
Total Current Liabilities  (as reported)87,573
Total Current Liabilities  (calculated)100,042
+/- 12,469
Long-term Liabilities
Long term Debt 96,731
Capital Lease Obligations 7,457
Other Liabilities 27,832
Deferred Long Term Liability 954
Long-term Liabilities  (as reported)339,403
Long-term Liabilities  (calculated)132,974
+/- 206,429
Total Stockholder Equity
Common Stock6,699
Retained Earnings -1,056,528
Accumulated Other Comprehensive Income 147,203
Other Stockholders Equity 1,007,409
Total Stockholder Equity (as reported)104,783
Total Stockholder Equity (calculated)104,783
+/-0
Other
Capital Stock6,699
Cash and Short Term Investments 380,860
Common Stock Shares Outstanding 78,373
Liabilities and Stockholders Equity 531,759
Net Debt -264,203
Net Invested Capital 213,983
Net Tangible Assets 91,139
Net Working Capital 350,526
Short Long Term Debt Total 116,657



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-03-312010-09-302010-06-302010-03-312009-12-312009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-31
> Total Assets 
1,814,519
2,425,671
4,001,300
3,970,500
3,722,000
2,972,300
2,697,000
2,499,700
2,340,900
2,290,000
1,574,400
1,144,200
1,063,400
951,800
1,293,300
1,296,900
1,290,100
1,250,600
1,354,600
1,428,100
1,432,900
1,499,200
1,516,200
1,535,000
1,514,700
1,568,500
1,574,200
1,611,400
1,598,200
1,716,500
1,737,400
1,764,800
2,205,100
2,234,500
2,051,800
1,921,000
1,316,900
1,307,500
1,322,700
1,336,100
1,345,100
1,415,000
1,474,500
0
200,839
200,839
0
137,682
0
373,842
521,526
513,692
461,705
464,386
637,979
617,972
581,886
520,463
531,759
531,759520,463581,886617,972637,979464,386461,705513,692521,526373,8420137,6820200,839200,83901,474,5001,415,0001,345,1001,336,1001,322,7001,307,5001,316,9001,921,0002,051,8002,234,5002,205,1001,764,8001,737,4001,716,5001,598,2001,611,4001,574,2001,568,5001,514,7001,535,0001,516,2001,499,2001,432,9001,428,1001,354,6001,250,6001,290,1001,296,9001,293,300951,8001,063,4001,144,2001,574,4002,290,0002,340,9002,499,7002,697,0002,972,3003,722,0003,970,5004,001,3002,425,6711,814,519
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
185,396
185,396
122,606
122,606
0
359,125
506,419
450,450
393,242
394,432
568,408
525,182
487,710
424,442
438,099
438,099424,442487,710525,182568,408394,432393,242450,450506,419359,1250122,606122,606185,396185,39600000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
141,200
118,900
149,000
520,200
792,600
813,300
656,500
631,400
515,800
462,300
511,600
558,500
446,200
449,200
518,100
0
182,156
182,156
0
115,551
0
348,593
494,416
439,195
383,122
371,884
530,194
466,544
430,874
376,778
380,860
380,860376,778430,874466,544530,194371,884383,122439,195494,416348,5930115,5510182,156182,1560518,100449,200446,200558,500511,600462,300515,800631,400656,500813,300792,600520,200149,000118,900141,2000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
420,800
537,200
528,700
61,600
3,300
200
200
100
0
0
0
51,000
111,300
181,000
178,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000178,800181,000111,30051,0000001002002003,30061,600528,700537,200420,8000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
1,362
0
0
0
0
1,699
0
2,079
15,896
31,037
26,752
20,863
23,251
23,25120,86326,75231,03715,8962,07901,69900001,3623300000000000000000000000000000000000000000000
       Other Current Assets 
52,085
62,052
190,287
96,300
406,900
279,500
281,000
349,100
224,800
197,400
167,900
171,100
75,700
54,200
44,700
48,600
76,800
42,000
61,500
41,700
35,600
34,200
34,900
33,400
44,100
47,200
53,200
46,400
37,300
32,300
30,500
32,500
37,400
33,400
33,700
42,600
45,800
42,900
33,000
30,100
38,800
36,600
51,900
0
3,237
3,237
1,478
1,743
0
10,532
12,003
1,401
10,120
12,751
14,310
1,129
18,246
12,151
18,243
18,24312,15118,2461,12914,31012,75110,1201,40112,00310,53201,7431,4783,2373,237051,90036,60038,80030,10033,00042,90045,80042,60033,70033,40037,40032,50030,50032,30037,30046,40053,20047,20044,10033,40034,90034,20035,60041,70061,50042,00076,80048,60044,70054,20075,700171,100167,900197,400224,800349,100281,000279,500406,90096,300190,28762,05252,085
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,443
0
15,076
0
14,717
15,107
63,242
68,463
69,954
69,571
92,790
94,176
96,021
93,660
93,66096,02194,17692,79069,57169,95468,46363,24215,10714,717015,076015,443000000000000000000000000000000000000000000000
       Property Plant Equipment 
343,277
384,133
496,426
608,600
682,600
724,900
734,100
614,000
580,600
540,800
318,900
206,800
190,700
170,900
206,900
192,300
182,700
169,600
240,500
233,000
229,000
219,000
217,300
221,100
218,100
211,800
210,300
206,500
204,500
204,300
201,900
199,200
201,000
202,700
200,800
177,100
169,300
168,900
166,900
158,300
153,800
147,900
146,500
0
6,760
6,760
6,274
6,274
0
5,508
4,904
4,758
10,543
11,338
11,562
11,230
10,664
9,690
9,877
9,8779,69010,66411,23011,56211,33810,5434,7584,9045,50806,2746,2746,7606,7600146,500147,900153,800158,300166,900168,900169,300177,100200,800202,700201,000199,200201,900204,300204,500206,500210,300211,800218,100221,100217,300219,000229,000233,000240,500169,600182,700192,300206,900170,900190,700206,800318,900540,800580,600614,000734,100724,900682,600608,600496,426384,133343,277
       Goodwill 
0
0
0
0
0
0
0
0
140,100
144,000
143,600
3,800
3,800
0
0
4,800
0
0
175,700
180,100
180,100
175,800
172,500
240,500
240,200
240,200
240,200
238,500
238,500
239,000
239,000
238,400
349,600
349,000
353,900
359,300
0
0
0
5,600
5,900
6,000
6,100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000006,1006,0005,9005,600000359,300353,900349,000349,600238,400239,000239,000238,500238,500240,200240,200240,200240,500172,500175,800180,100180,100175,700004,800003,8003,800143,600144,000140,10000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47,908
47,381
46,212
44,002
41,236
38,734
36,817
34,687
34,68736,81738,73441,23644,00246,21247,38147,908000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
140,100
144,000
143,600
3,800
3,800
0
0
26,700
0
0
249,600
273,100
270,300
263,700
262,400
405,500
398,900
393,100
386,600
380,500
374,800
370,200
365,200
360,300
537,800
528,200
525,500
520,400
105,800
99,800
94,900
94,600
89,800
85,400
81,900
0
8,419
8,419
0
8,434
0
187,477
0
10,179
0
12,010
13,316
13,582
13,851
14,575
14,598
14,59814,57513,85113,58213,31612,010010,1790187,47708,43408,4198,419081,90085,40089,80094,60094,90099,800105,800520,400525,500528,200537,800360,300365,200370,200374,800380,500386,600393,100398,900405,500262,400263,700270,300273,100249,6000026,700003,8003,800143,600144,000140,10000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
264
0
368
0
-178,268
10,203
48,305
392
394
691
693
1,022
899
899
8998991,02269369139439248,30510,203-178,26803680264000000000000000000000000000000000000000000000
> Total Liabilities 
418,514
655,076
1,144,428
1,057,800
1,145,200
828,800
664,000
606,300
513,200
549,000
475,600
412,000
371,100
285,400
675,800
669,200
656,900
642,300
759,100
768,800
720,000
750,200
738,800
761,100
731,700
757,200
746,400
737,900
718,800
736,500
735,800
757,200
1,218,300
1,223,400
1,015,900
1,006,800
947,400
940,800
943,300
977,000
989,800
985,600
1,040,100
0
22,850
22,850
0
26,526
0
177,540
145,467
178,187
163,737
220,468
450,671
451,884
419,219
405,117
426,976
426,976405,117419,219451,884450,671220,468163,737178,187145,467177,540026,526022,85022,85001,040,100985,600989,800977,000943,300940,800947,4001,006,8001,015,9001,223,4001,218,300757,200735,800736,500718,800737,900746,400757,200731,700761,100738,800750,200720,000768,800759,100642,300656,900669,200675,800285,400371,100412,000475,600549,000513,200606,300664,000828,8001,145,2001,057,8001,144,428655,076418,514
   > Total Current Liabilities 
405,398
633,522
1,125,643
1,041,300
1,130,200
818,500
654,200
599,400
491,800
544,300
471,200
397,800
353,600
282,000
272,500
265,500
254,400
239,900
293,700
302,000
250,600
280,300
273,700
286,600
250,800
275,300
263,500
260,100
237,900
253,000
447,800
474,100
470,200
471,700
264,200
278,000
212,900
207,200
210,800
230,700
251,900
255,900
288,700
0
17,005
17,005
19,943
19,943
0
31,368
32,563
40,436
41,398
51,499
59,300
73,935
70,774
73,684
87,573
87,57373,68470,77473,93559,30051,49941,39840,43632,56331,368019,94319,94317,00517,0050288,700255,900251,900230,700210,800207,200212,900278,000264,200471,700470,200474,100447,800253,000237,900260,100263,500275,300250,800286,600273,700280,300250,600302,000293,700239,900254,400265,500272,500282,000353,600397,800471,200544,300491,800599,400654,200818,5001,130,2001,041,3001,125,643633,522405,398
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,087
0
0
0
4,212
3,693
0
0
7,181
7,587
0
0
0
13,304
13,3040007,5877,181003,6934,2120001,087000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,113
2,642
3,631
3,594
6,193
6,575
6,575
6,549
6,573
12,469
12,4696,5736,5496,5756,5756,1933,5943,6312,6423,1130000000000000000000000000000000000000000000000000
       Accounts payable 
103,291
139,158
210,531
211,300
232,100
211,700
179,200
162,000
107,100
105,400
80,900
73,000
62,300
49,200
46,100
49,300
49,200
51,800
68,800
72,800
72,700
86,500
80,400
77,400
81,400
103,900
104,200
88,400
82,900
96,600
92,000
92,500
106,200
103,500
95,900
99,100
75,900
72,500
77,800
73,600
77,300
82,200
97,200
0
1,166
1,166
3,329
3,329
0
6,797
6,146
5,279
11,462
14,631
12,028
12,080
16,453
13,019
11,611
11,61113,01916,45312,08012,02814,63111,4625,2796,1466,79703,3293,3291,1661,166097,20082,20077,30073,60077,80072,50075,90099,10095,900103,500106,20092,50092,00096,60082,90088,400104,200103,90081,40077,40080,40086,50072,70072,80068,80051,80049,20049,30046,10049,20062,30073,00080,900105,400107,100162,000179,200211,700232,100211,300210,531139,158103,291
       Other Current Liabilities 
216,088
265,152
377,513
435,700
357,900
482,400
473,300
435,700
383,000
422,200
373,600
309,100
275,500
224,200
217,900
169,900
197,700
188,100
200,500
201,300
152,400
167,600
173,600
193,000
153,100
153,800
141,600
154,000
136,900
138,300
141,700
165,500
139,900
159,700
159,800
173,900
133,100
132,400
132,400
153,200
172,100
170,300
186,500
0
14,752
14,752
834
834
0
-148
22,633
3,128
25,509
29,450
39,685
9,669
37,080
41,165
62,658
62,65841,16537,0809,66939,68529,45025,5093,12822,633-148083483414,75214,7520186,500170,300172,100153,200132,400132,400133,100173,900159,800159,700139,900165,500141,700138,300136,900154,000141,600153,800153,100193,000173,600167,600152,400201,300200,500188,100197,700169,900217,900224,200275,500309,100373,600422,200383,000435,700473,300482,400357,900435,700377,513265,152216,088
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,845
0
6,583
0
32,855
112,904
137,751
122,339
168,969
391,371
377,949
348,445
331,433
339,403
339,403331,433348,445377,949391,371168,969122,339137,751112,90432,85506,58305,845000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
6,100
3,900
3,700
3,700
3,600
3,400
3,200
3,400
3,300
3,700
2,500
2,400
65,000
66,800
69,400
69,900
65,100
74,500
80,900
81,900
82,900
49,100
80,900
83,500
87,400
40,200
96,800
100,700
100,900
23,200
84,000
83,200
81,500
95,400
87,000
78,800
78,200
0
1,556
1,556
2,684
2,684
0
109,983
76,511
100,511
78,967
76,709
83,682
65,138
49,312
31,176
27,832
27,83231,17649,31265,13883,68276,70978,967100,51176,511109,98302,6842,6841,5561,556078,20078,80087,00095,40081,50083,20084,00023,200100,900100,70096,80040,20087,40083,50080,90049,10082,90081,90080,90074,50065,10069,90069,40066,80065,0002,4002,5003,7003,3003,4003,2003,4003,6003,7003,7003,9006,100000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
926
631
713
894
954
954894713631926000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
1,396,005
1,770,595
2,856,872
2,912,700
2,576,800
2,143,500
2,033,000
1,893,400
1,827,700
1,741,000
1,098,800
732,200
692,300
666,400
617,500
627,700
633,200
608,300
595,500
659,300
712,900
749,000
777,400
773,900
783,000
811,300
827,800
873,500
879,400
980,000
1,001,600
1,007,600
986,800
1,011,100
1,035,900
914,200
369,500
366,700
379,400
354,300
350,400
424,600
429,600
249,166
177,989
177,989
0
111,156
0
196,302
376,059
335,505
297,968
243,918
187,308
166,088
162,667
115,346
104,783
104,783115,346162,667166,088187,308243,918297,968335,505376,059196,3020111,1560177,989177,989249,166429,600424,600350,400354,300379,400366,700369,500914,2001,035,9001,011,100986,8001,007,6001,001,600980,000879,400873,500827,800811,300783,000773,900777,400749,000712,900659,300595,500608,300633,200627,700617,500666,400692,300732,2001,098,8001,741,0001,827,7001,893,4002,033,0002,143,5002,576,8002,912,7002,856,8721,770,5951,396,005
   Common Stock
30,337
61,337
141,805
154,100
156,160
157,800
157,860
158,400
158,800
159,300
159,300
159,900
160,360
160,820
160,820
161,300
161,540
161,760
161,800
162,000
161,940
162,120
23,280
23,300
23,400
23,400
23,400
23,500
23,400
23,500
23,500
23,500
23,500
23,500
23,500
23,500
19,000
19,000
19,000
19,000
19,000
23,700
23,700
0
424
424
4,361
4,361
0
5,795
6,314
6,314
6,314
6,445
6,445
6,445
6,445
6,445
6,699
6,6996,4456,4456,4456,4456,4456,3146,3146,3145,79504,3614,361424424023,70023,70019,00019,00019,00019,00019,00023,50023,50023,50023,50023,50023,50023,50023,40023,50023,40023,40023,40023,30023,280162,120161,940162,000161,800161,760161,540161,300160,820160,820160,360159,900159,300159,300158,800158,400157,860157,800156,160154,100141,80561,33730,337
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,784
0
0
0
16,508
27,647
0
0
75,272
89,930
0
0
0
147,203
147,20300089,93075,2720027,64716,5080005,784000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
527,083
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000527,083000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,425
547,889
5,542
5,542
0
792,601
981,028
42,998
56,985
981,156
981,437
102,829
116,069
133,122
1,007,409
1,007,409133,122116,069102,829981,437981,15656,98542,998981,028792,60105,5425,542547,88932,42500000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.